Provectus Biopharma Company Profile (NYSE:PVCT)

About Provectus Biopharma

Provectus Biopharma logoProvectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company. The Company is engaged in developing pharmaceuticals for oncology and dermatology indications. The Company is focused on developing its prescription drug candidates, PV-10 and PH-10. It is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer and breast cancer. It is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions, such as psoriasis and atopic dermatitis, a type of eczema. In addition to clinical trials, patients enrolled in the expanded access or compassionate use program for PV-10 are also receiving PV-10 treatments for cutaneous and subcutaneous cancer indications. The Company also focuses on over-the-counter (OTC) products and various other non-core technologies. PV-10 is a sterile injectable form of rose bengal disodium (Rose Bengal), for direct injection into tumors.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: PVCT
  • CUSIP:
Key Metrics:
  • Previous Close: $0.06
  • 50 Day Moving Average: $0.09
  • 200 Day Moving Average: $0.28
  • 52-Week Range: $212,829,000.00 - $0.03
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.43
  • P/E Growth: 0.00
  • Market Cap: $13.17M
  • Outstanding Shares: 212,829,000
Additional Links:
Companies Related to Provectus Biopharma:

Analyst Ratings

Consensus Ratings for Provectus Biopharma (NYSE:PVCT) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Provectus Biopharma (NYSE:PVCT)
No equities research coverage for this company has been tracked by


Earnings History for Provectus Biopharma (NYSE:PVCT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2016Q116($0.04)ViewListenView Earnings Details
3/30/2016Q415($0.05)$1.08 millionViewListenView Earnings Details
11/5/2015Q315($0.03)$1.08 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Provectus Biopharma (NYSE:PVCT)
Current Year EPS Consensus Estimate: $-0.12 EPS
Next Year EPS Consensus Estimate: $-0.14 EPS


Dividend History for Provectus Biopharma (NYSE:PVCT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Provectus Biopharma (NYSE:PVCT)
No insider trades for this company have been tracked by


Latest Headlines for Provectus Biopharma (NYSE:PVCT)
DateHeadline logoTrading in Provectus Biopharmaceuticals Common Stock and Warrants Suspended by NYSE MKT (NYSE:PVCT) - October 14 at 6:40 PM logoNYSE MKT to Suspend Trading of Provectus Biopharma (PVCT) Shares; Will Move to Delist (NYSE:PVCT) - October 13 at 7:03 PM
News Icon8-K: PROVECTUS BIOPHARMACEUTICALS, INC. (NYSE:PVCT) - September 28 at 12:06 PM logoProvectus prices equity offering; shares plummet 48% (NYSE:PVCT) - August 25 at 7:08 PM logoProvectus announces pricing of public offering to raise $6mln (NYSE:PVCT) - August 25 at 7:08 PM logoProvectus reports 2Q loss (NYSE:PVCT) - August 10 at 10:05 AM logoProvectus Biopharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results (NYSE:PVCT) - August 9 at 7:15 PM logoProvectus Biopharmaceuticals reports Q2 results (NYSE:PVCT) - August 9 at 5:19 PM logoProvectus Biopharmaceuticals Will Hold Its 2016 Second Quarter Business Update Conference Call on Wednesday, … (NYSE:PVCT) - July 20 at 9:50 AM logoProvectus Biopharma establishes Australian Subsidiary (NYSE:PVCT) - July 14 at 10:37 AM logoProvectus Biopharmaceuticals Will Present at 2016 BIO International Convention in San Francisco, CA (NYSE:PVCT) - June 7 at 7:08 AM logoProvectus Biopharmaceuticals Launches Newly Redesigned Website and Official Facebook Page (NYSE:PVCT) - June 1 at 8:03 AM


Provectus Biopharma (NYSE:PVCT) Chart for Friday, October, 21, 2016

Last Updated on 10/21/2016 by Staff